Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 1
1968 1
1970 1
1971 2
1972 6
1973 18
1974 15
1975 30
1976 35
1977 29
1978 16
1979 18
1980 20
1981 24
1982 14
1983 22
1984 15
1985 11
1986 15
1987 17
1988 13
1989 9
1990 19
1991 22
1992 5
1993 14
1994 6
1995 12
1996 6
1997 6
1998 13
1999 7
2000 18
2001 8
2002 14
2003 32
2004 40
2005 44
2006 51
2007 71
2008 52
2009 64
2010 92
2011 113
2012 145
2013 135
2014 145
2015 185
2016 225
2017 282
2018 397
2019 589
2020 870
2021 1003
2022 1092
2023 1084
2024 1123
2025 1172
2026 181

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,480 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for cannabidiol
Your search for cannabidiolo retrieved no results
Cannabidiol Adverse Effects and Toxicity.
Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP. Huestis MA, et al. Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901. Curr Neuropharmacol. 2019. PMID: 31161980 Free PMC article. Review.
BACKGROUND: Currently, there is a great interest in the potential medical use of cannabidiol (CBD), a non-intoxicating cannabinoid. Productive pharmacological research on CBD occurred in the 1970s and intensified recently with many discoveries about the endocannabinoid sys …
BACKGROUND: Currently, there is a great interest in the potential medical use of cannabidiol (CBD), a non-intoxicating cannabinoid. P …
Endometriosis: cannabidiol therapy for symptom relief.
Whitaker LHR, Page C, Morgan C, Horne AW, Saunders PTK. Whitaker LHR, et al. Trends Pharmacol Sci. 2024 Dec;45(12):1150-1161. doi: 10.1016/j.tips.2024.10.014. Epub 2024 Nov 14. Trends Pharmacol Sci. 2024. PMID: 39547915 Free article. Review.
Recent advances in our understanding of the mechanisms that contribute to the development of lesions and pain experience in endometriosis as well as surveys of patients have increased interest in testing recently approved formulations containing cannabidiol (CBD) in this p …
Recent advances in our understanding of the mechanisms that contribute to the development of lesions and pain experience in endometriosis as …
Cannabidiol and epilepsy.
Moreira FA, de Oliveira ACP, Santos VR, Moraes MFD. Moreira FA, et al. Int Rev Neurobiol. 2024;177:135-147. doi: 10.1016/bs.irn.2024.03.009. Epub 2024 Apr 6. Int Rev Neurobiol. 2024. PMID: 39029983 Review.
Cannabidiol (CBD) has been investigated as a pharmacological approach for treating a myriad of neurological and psychiatric disorders, the most successful of them being its use as an antiseizure drug (ASD). ...
Cannabidiol (CBD) has been investigated as a pharmacological approach for treating a myriad of neurological and psychiatric disorders …
Cannabidiol and addiction.
Briânis RC, Moreira FA, Iglesias LP. Briânis RC, et al. Int Rev Neurobiol. 2024;177:319-333. doi: 10.1016/bs.irn.2024.03.006. Epub 2024 Jul 3. Int Rev Neurobiol. 2024. PMID: 39029990 Review.
Cannabidiol (CBD) has been investigated for several therapeutic applications, having reached the clinics for the treatment of certain types of epilepsies. ...
Cannabidiol (CBD) has been investigated for several therapeutic applications, having reached the clinics for the treatment of certain …
Cannabidiol-A friend or a foe?
Tihăuan BM, Onisei T, Slootweg W, Gună D, Iliescu C, Chifiriuc MC. Tihăuan BM, et al. Eur J Pharm Sci. 2025 May 1;208:107036. doi: 10.1016/j.ejps.2025.107036. Epub 2025 Feb 8. Eur J Pharm Sci. 2025. PMID: 39929375 Free article. Review.
Cannabidiol (CBD), one of the main actives from Cannabis sativa has been perpetually explored lately for its therapeutic effects. ...The present work critically examines the transdermal administration of cannabidiol, explores the skin's potential as a route and the …
Cannabidiol (CBD), one of the main actives from Cannabis sativa has been perpetually explored lately for its therapeutic effects. ... …
Cannabidiol--recent advances.
Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO. Mechoulam R, et al. Chem Biodivers. 2007 Aug;4(8):1678-92. doi: 10.1002/cbdv.200790147. Chem Biodivers. 2007. PMID: 17712814 Review.
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non-psychoactive constituent of Cannabis, and to give a general overview. ...
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non-psychoactive constituent of …
Cannabidiol in experimental cerebral ischemia.
de Oliveira RMW, Kohara NA, Milani H. de Oliveira RMW, et al. Int Rev Neurobiol. 2024;177:95-120. doi: 10.1016/bs.irn.2024.04.012. Epub 2024 Jul 9. Int Rev Neurobiol. 2024. PMID: 39029992 Review.
Therefore, there is an imperative to explore innovative strategies for addressing CI outcomes. Cannabidiol (CBD), the most abundant non-psychotomimetic compound derived from Cannabis sativa, is a pleiotropic substance that interacts with diverse molecular targets and has t …
Therefore, there is an imperative to explore innovative strategies for addressing CI outcomes. Cannabidiol (CBD), the most abundant n …
The role of cannabidiol in aging.
Ni B, Liu Y, Dai M, Zhao J, Liang Y, Yang X, Han B, Jiang M. Ni B, et al. Biomed Pharmacother. 2023 Sep;165:115074. doi: 10.1016/j.biopha.2023.115074. Epub 2023 Jul 6. Biomed Pharmacother. 2023. PMID: 37418976 Free article. Review.
It is of great significance to search for drugs to extend lifespan and healthspan. Cannabidiol (CBD), a natural nontoxic phytocannabinoid, has been regarded as a potential candidate drug for antiaging. ...
It is of great significance to search for drugs to extend lifespan and healthspan. Cannabidiol (CBD), a natural nontoxic phytocannabi …
Current Cannabidiol Safety: A Review.
Singh C, Rao K, Yadav N, Vashist Y, Chugh P, Bansal N, Minocha N. Singh C, et al. Curr Drug Saf. 2023;18(4):465-473. doi: 10.2174/1574886317666220902100511. Curr Drug Saf. 2023. PMID: 36056846 Review.
OBJECTIVES: This study aims to provide an enhanced review of cannabidiol properties used in treating inflammation. This review also emphasises the current safety profile of cannabidiol. ...Conclusion: Cannabis contains chemical compounds such as the cannabinoids del …
OBJECTIVES: This study aims to provide an enhanced review of cannabidiol properties used in treating inflammation. This review also e …
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, VanLandingham KE, Zuberi SM; GWPCARE3 Study Group. Devinsky O, et al. N Engl J Med. 2018 May 17;378(20):1888-1897. doi: 10.1056/NEJMoa1714631. N Engl J Med. 2018. PMID: 29768152 Free article. Clinical Trial.
The median percent reduction from baseline in drop-seizure frequency during the treatment period was 41.9% in the 20-mg cannabidiol group, 37.2% in the 10-mg cannabidiol group, and 17.2% in the placebo group (P=0.005 for the 20-mg cannabidiol group vs. placeb …
The median percent reduction from baseline in drop-seizure frequency during the treatment period was 41.9% in the 20-mg cannabidiol g …
8,480 results